Submitted:
07 August 2025
Posted:
13 August 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction to Skin Disorders as Markers of Gastrointestinal Pathology
1.1. Background
1.2. The Cutaneous-Gastrointestinal Connection
1.2.1. Immune System Interactions
1.2.2. Nutritional Absorption
1.2.3. Microbiome Interactions
1.3. Common Skin Disorders Associated with Gastrointestinal Pathologies
1.3.1. Psoriasis
1.3.2. Eczema (Atopic Dermatitis)
1.3.3. Dermatitis Herpetiformis
1.3.4. Acne Vulgaris
1.4. Importance of Recognizing Skin Disorders as Markers of GI Pathology
1.4.1. Improved Diagnostic Accuracy
1.4.2. Holistic Patient Management
1.4.3. Enhanced Patient Education
1.5. Conclusion
2. The Interrelationship Between Skin Disorders and Gastrointestinal Pathology
2.1. Introduction
2.2. Pathophysiological Connections
2.2.1. Immune System Interactions
2.2.2. Nutritional Deficiencies
2.2.3. Microbiome Influence
2.3. Common Skin Disorders Associated with Gastrointestinal Pathology
2.3.1. Erythema Nodosum
Pathophysiology
Diagnosis and Management
2.3.2. Pyoderma Gangrenosum
Pathophysiology
Diagnosis and Management
2.3.3. Dermatitis Herpetiformis
Pathophysiology
Diagnosis and Management
2.3.4. Acneiform Eruptions
Pathophysiology
Diagnosis and Management
2.4. Diagnostic Approaches
2.4.1. Comprehensive Patient History
2.4.2. Physical Examination
2.4.3. Laboratory Investigations
2.5. Implications for Patient Management
- Early Diagnosis: Identifying skin manifestations can lead to earlier diagnosis and treatment of underlying gastrointestinal disorders.
- Interdisciplinary Collaboration: Collaboration between dermatologists and gastroenterologists is crucial for comprehensive care, ensuring that both skin and GI conditions are addressed.
- Patient Education: Educating patients about the relationship between skin and gastrointestinal health can empower them to seek timely medical attention for emerging symptoms.
2.6. Conclusion
3. Pathophysiological Mechanisms Linking Skin Disorders and Gastrointestinal Pathology
3.1. Introduction
3.2. Immune Dysregulation
3.2.1. Systemic Inflammation
3.2.2. Autoimmune Mechanisms
3.3. Nutrient Malabsorption
3.3.1. Deficiencies and Skin Health
3.3.2. Role of the Gut Microbiome
3.4. Genetic Predisposition
3.4.1. Familial Links
3.4.2. Shared Genetic Pathways
3.5. Environmental Factors
3.5.1. Dietary Influences
3.5.2. Toxins and Irritants
3.6. Interdisciplinary Implications
3.6.1. Importance of Collaboration
3.6.2. Integrated Treatment Strategies
3.7. Conclusion
4. Pathophysiological Mechanisms Linking Skin Disorders and Gastrointestinal Pathology
4.1. Introduction
4.2. Immune Dysregulation
4.2.1. The Immune System and Skin
4.2.2. Immune-Mediated GI Disorders
4.2.3. Cytokine Networks
4.3. Nutrient Malabsorption
4.3.1. The Role of Nutrients in Skin Health
4.3.2. Skin Manifestations of Malabsorption
4.3.3. The Role of the Gut Microbiome
4.4. Systemic Inflammation
4.4.1. The Inflammatory Cascade
4.4.2. Cutaneous Signs of Systemic Inflammation
4.4.3. The Impact of Chronic Inflammation
4.5. Genetic and Environmental Factors
4.5.1. Genetic Predisposition
4.5.2. Environmental Triggers
4.6. Conclusion
5. The Interrelationship Between Skin Disorders and Gastrointestinal Pathology
5.1. Introduction
5.2. Mechanisms Linking Skin and Gastrointestinal Health
5.2.1. Immune Dysregulation
5.2.2. Nutritional Deficiencies
5.2.3. Alterations in the Gut Microbiome
5.3. Skin Disorders as Indicators of Gastrointestinal Pathology
5.3.1. Dermatitis Herpetiformis and Celiac Disease
5.3.2. Psoriasis and Inflammatory Bowel Disease
5.3.3. Erythema Nodosum and IBD
5.3.4. Acne and Hormonal Dysregulation
5.4. Diagnostic and Therapeutic Implications
5.4.1. Interdisciplinary Collaboration
5.4.2. Screening and Early Intervention
5.4.3. Personalized Treatment Strategies
5.5. Conclusion
6. Interdisciplinary Considerations in the Management of Skin Disorders as Markers of Gastrointestinal Pathology
6.1. Introduction
6.2. Understanding the Skin-GI Connection
6.2.1. Pathophysiological Mechanisms
- Immune Dysregulation: Many skin disorders are associated with immune system dysfunction, which can also manifest in the GI tract. For instance, conditions like psoriasis and atopic dermatitis may indicate systemic inflammation that correlates with GI diseases such as inflammatory bowel disease (IBD).
- Nutritional Deficiencies: GI disorders can lead to malabsorption of vital nutrients, which may manifest as skin symptoms. For example, deficiencies in zinc, biotin, or essential fatty acids can result in dermatitis or hair loss.
- Microbiome Alterations: The gut microbiome plays a crucial role in maintaining skin health. Dysbiosis in the gut can contribute to inflammatory skin conditions, highlighting the need to consider gut health when addressing skin issues.
6.2.2. Clinical Implications
6.3. Role of Dermatologists in GI Evaluation
- Celiac Disease: Dermatitis herpetiformis is a classic skin manifestation of celiac disease, characterized by itchy, vesicular lesions. Dermatologists can aid in diagnosis through skin biopsy and serological tests, such as tissue transglutaminase antibodies.
- Psoriasis and IBD: Patients with psoriasis are at an increased risk for developing IBD. Dermatologists should be vigilant for gastrointestinal symptoms in patients with psoriasis and consider referral to a gastroenterologist for further evaluation.
- Liver Disease: Skin changes, such as pruritus and xanthomas, may indicate hepatic dysfunction. Dermatologists can facilitate liver function assessments and collaborate with hepatologists for comprehensive management.
6.4. Role of Gastroenterologists in Dermatological Evaluation
- Screening for Skin Conditions: Patients with chronic GI disorders, such as Crohn’s disease or ulcerative colitis, should be screened for associated skin conditions. Early identification can lead to more effective management of both GI and skin symptoms.
- Addressing Nutritional Deficiencies: Gastroenterologists should evaluate patients for potential nutritional deficiencies linked to malabsorption, which may manifest as skin disorders. Nutritional counseling and supplementation can significantly improve skin health.
6.5. Patient Education and Empowerment
- Recognizing Symptoms: Patients should be encouraged to report any skin changes, such as rashes or itching, alongside gastrointestinal symptoms. This awareness can facilitate timely referrals and interventions.
- Lifestyle Modifications: Patients should receive guidance on dietary modifications that may alleviate both skin and GI symptoms. For example, a gluten-free diet can benefit individuals with celiac disease, improving both skin and gastrointestinal health.
- Adherence to Treatment: Emphasizing the importance of adhering to prescribed treatments for both skin and GI conditions can enhance overall patient outcomes.
6.6. Future Directions
6.7. Conclusion
References
- Krishnan, S., Shah, K., Dhillon, G., & Presberg, K. (2016). 1995: FATAL PURPURA FULMINANS AND FULMINANT PSEUDOMONAL SEPSIS. Critical Care Medicine, 44(12), 574.
- Hajj, F., Singh, V., Al Akoum, N., Patil, N., Ahmad, F.N., Chuecos, A., Vemana, P., González, G., Makkieh, Y., Al Farou, D., Paul, J., & Siddiqui, H.F. (2024). Skin as a reflection of gut health: An overview of dermatological manifestations in primary neoplastic and autoimmune gastrointestinal disorders. Cureus, 16(10), e71313. PMC. [CrossRef]
- Antonelli, E., Bassotti, G., Tramontana, M., Hansel, K., Stingeni, L., Ardizzone, S., Genovese, G., & Marzano, A.V. (2021). Dermatological manifestations in inflammatory bowel diseases. Journal of Clinical Medicine, 10(2), 364. PMC. [CrossRef]
- Ungureanu, L., Cosgarea, R., Badea, M.A., Vasilovici, A.F., Cosgarea, I., & Șenilă, S.C. (2020). Cutaneous manifestations in inflammatory bowel disease (Review). Experimental and Therapeutic Medicine, 20, 31–37. Spandidos Publications. [CrossRef]
- Rahvar, M., & Kerstetter, J. (2025). Cutaneous manifestation of gastrointestinal disease. Journal of Gastrointestinal Oncology. (Review) jgo.amegroups.org.
- Shah, K.R., Boland, C.R., Patel, M., Thrash, B., & Menter, A. (2013). Cutaneous manifestations of gastrointestinal disease: Part I. Journal of the American Academy of Dermatology, 68(2 Pt 2), 189.e1–21. PubMed+1. [CrossRef]
- Thrash, B., Patel, M., Shah, K.R., Boland, C.R., & Menter, A. (2013). Cutaneous manifestations of gastrointestinal disease: Part II. Journal of the American Academy of Dermatology, 68(2), 211.e1–33. PubMed+1. [CrossRef]
- “Atlas of Dermatological Manifestations in Gastrointestinal Disease.” (2020). In Geriatric Gastroenterology (pp. 1–26). Springer. SpringerLink.
- DermNet NZ. (n.d.). Skin signs of gastrointestinal disease. DermNet New Zealand. DermNet®.
- Wikipedia contributors. (2025). Necrolytic migratory erythema. In Wikipedia. Retrieved August 2025. Wikipedia.
- Wikipedia contributors. (2025). Henoch–Schönlein purpura. In Wikipedia. Retrieved August 2025. Wikipedia.
- Wikipedia contributors. (2025). Dermatitis herpetiformis. In Wikipedia. Retrieved August 2025. Wikipedia.
- Wikipedia contributors. (2025). Peutz–Jeghers syndrome. In Wikipedia. Retrieved August 2025. Wikipedia.
- Wikipedia contributors. (2025). Ulcerative colitis. In Wikipedia. Retrieved August 2025. Wikipedia.
- Wikipedia contributors. (2025). Febrile neutrophilic dermatosis (Sweet syndrome). In Wikipedia. Retrieved August 2025. Wikipedia.
- Korotky, N., & Peslyak, M. (2011). Psoriasis as a consequence of incorporation of beta-streptococci into the microbiocenosis of highly permeable intestines (a pathogenic concept). arXiv. arXiv.
- Antonelli, E., Bassotti, G., Tramontana, M., et al. (2021). [Duplicate entry—only keep unique ones].
- Duarte, M., & Milikowski, C. (2022). Gastrointestinal polyposis with associated cutaneous manifestations. Pathology, 54(2), 157–166. PubMed. [CrossRef]
- Boland, C.R., Idos, G.E., Durno, C., Giardiello, F.M., et al. (2022). Diagnosis and management of cancer risk in gastrointestinal hamartomatous polyposis syndromes: Recommendations from the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 162(7), 2063–2085. PubMed. [CrossRef]
- Arnold, J.C., et al. (2012). Kaposi sarcoma involving skin and gastrointestinal tract. Journal of the American Academy of Dermatology. (Exact details not found).
- Oldfield, C.W., Heffernan-Stroud, L.A., Buehler-Bota, T.S., & Williams, J.V. (2016). Bowel-associated dermatosis-arthritis syndrome (BADAS) in a pediatric patient. JAAD Case Reports, 2(3), 272–274. PubMed+1. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).